Clinical Trials Logo

Osteoarthritis, Knee clinical trials

View clinical trials related to Osteoarthritis, Knee.

Filter by:

NCT ID: NCT05349682 Recruiting - Clinical trials for Osteoarthritis, Knee

Bayer OA Knee Pain Pilot

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to investigate if MRI can be used to evaluated effect of knee artery embolization for knee osteoarthritis. Participants be evaluated in clinic, obtain a knee MRI, undergo embolization of the symptomatic knee, and follow up in clinic at 1, 6, and 12 months after embolization. A second MRI is obtained 6 months after embolization. Participants will keep a record of their pain level and treatment and answer questionnaires at each visit. In addition, this study aims to determine the effects of knee artery embolization on the amount of opioid (pain reliever drugs) needed to manage osteoarthritis-associated pain and change in quality of life.

NCT ID: NCT05337540 Recruiting - Osteoarthritis Clinical Trials

A Study to Evaluate the Efficacy, Safety and Tolerability of EVI-01 Intra-Articular Injection in Osteoarthritis of the Knee

Start date: January 17, 2024
Phase: N/A
Study type: Interventional

Objective: Identifying the dose of EVI-01 with the best clinical response, balancing the efficacy, safety, and tolerability of the investigational product. Study design: Interventional, dose-finding, three arms, randomized (1:1:1), parallel assignment, double-blind, controlled by an active comparator.

NCT ID: NCT05336968 Recruiting - Clinical trials for Osteoarthritis, Knee

Triamcinolone Ketorolac (TriKe) Knee Trial

TriKe
Start date: September 15, 2022
Phase: Phase 4
Study type: Interventional

Cortisone injections are commonly used in the treatment of osteoarthrosis of the knee, but there are known detriments to cortisone including localized tissue atrophy near the injection site and acceleration of joint degeneration, as well as contraindications, such as uncontrolled diabetes. Ketorolac is a non-steroidal anti-inflammatory with decades of clinical data that is most commonly injected intramuscularly. There is rising interest in using ketorolac as an intra-articular injectant substitute or adjunctive to cortisone. This may potentially improve clinical outcomes or decrease adverse effects. Although intra-articular use of ketorolac is increasing in orthopedics and sports medicine, there is limited data in the literature comparing these two injectants in prospective, randomized trials, and no data that evaluates combining the two injectants. Primary objectives are to evaluate the efficacy of intra-articular ketorolac compared to cortisone on knee osteoarthrosis and to evaluate whether the combination of ketorolac and cortisone is superior to either alone.

NCT ID: NCT05329116 Recruiting - Clinical trials for Osteo Arthritis Knee

Efficacy of Mesotherapy Added to Intra-articular Platelet-rich Plasma (PRP) in Patients With Knee Osteoarthritis

Start date: May 15, 2022
Phase: N/A
Study type: Interventional

In this study, the investigators aimed to determine whether platelet rich plasma (PRP) and mesotherapy combined treatment is effective on pain and function compared to PRP alone in patients with knee osteoarthritis (OA).

NCT ID: NCT05327413 Recruiting - Knee Osteoarthritis Clinical Trials

Femoral External Rotation Measured on CT and MRI

Start date: April 1, 2022
Phase:
Study type: Observational

This study aims to compare the femoral external rotation measured on CT and MRI to that measured intraoperatively to clarify the influence of residual cartilage on posterior condyle on the preoperative planning of total knee arthroplasty.

NCT ID: NCT05318521 Recruiting - Clinical trials for Degenerative Arthritis

RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee

Start date: December 10, 2021
Phase: Phase 3
Study type: Interventional

It is a Phase III efficacy study as the title 'A randomized, double-blind, parallel-arm study comparing the efficacy of investigational product "Ibuprofen Modified-Release Tablets 800 mg" and placebo in patients with chronic pain related to osteoarthritis of the knee.' The primary objective is to determine the analgesic efficacy of orally administered IBUMR in patients with osteoarthritis (OA) of the knee. The Secondary objectives are to compare the treatment effect on patient pain, function and stiffness between IBUMR- and placebo-treated patients as measured by the Western Ontario and McMaster Osteoarthritis Index (WOMAC), to compare the treatment effect on Patient Global Assessment on Disease Activity between IBUMR- and placebo-treated patients, to compare the treatment effect on Investigator's Global Assessment on Disease Activity between IBUMR- and placebo-treated patients, to compare the use of analgesic rescue medicine between IBUMR- and placebo-treated patients, to determine the safety profile of IBUMR.

NCT ID: NCT05295602 Recruiting - Knee Osteoarthritis Clinical Trials

The Influence of Coronally Knee Alignment on the Tibial Tuberosity Rotation

Start date: December 1, 2021
Phase:
Study type: Observational

The primary aim of this study is to find a possible correlation between tibial tuberosity rotation and coronal leg alignment. If correlation exists, a more individual tibial component rotation might be proposed during a total knee arthroplasty.

NCT ID: NCT05291650 Recruiting - Clinical trials for Osteoarthritis, Knee

Ultrasound-guided Injection of Glucocorticoid Into Infrapatellar Fat Pad in Patients With Knee Osteoarthritis

Start date: April 25, 2022
Phase: Phase 4
Study type: Interventional

This aims of this study is to investigate the efficacy and safety of the glucocorticoid injection into the infrapatellar fat pad among knee osteoarthritis patients with an inflammatory phenotype.

NCT ID: NCT05290272 Recruiting - Knee Osteoarthritis Clinical Trials

Validity of AI in Treatment of the Musculoskeletal Conditions by Vifive

Start date: January 30, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of the 12-week ViFive program, a vision-based artificial intelligent digital care plan for chronic knee pain. ViFive digital care plan is delivered by a physical therapy team consisting of physical therapists and a personal coach. We aim to understand the safety and efficacy of this vision artificial intelligent based home exercise program.

NCT ID: NCT05286775 Recruiting - Clinical trials for Osteoarthritis, Knee

Knee Osteoarthritis Disabling Pain Program for the Brazilian Unified Health System

Start date: March 15, 2022
Phase: N/A
Study type: Interventional

This is a Randomized Clinical Trial to compare two interventions for reducing knee pain and improving knee function of patients with knee osteoarthritis. Sixty participants will be randomly allocated to one of the intervention groups, either a knee educational program or a combination of knee educational program and medical interventions. Participants will be assessed primarily on function and pain, as well as other secondary outcomes at baseline, at the end of the interventions, and three months after the end of the interventions.